FDA
approval
· 2022-04-29
FDA Approved: VYLIBRA — Supplemental Application (Afaxys Pharma, LLC)
Summary
FDA approved a supplemental application for VYLIBRA (norgestimate and ethinyl estradiol) from Afaxys Pharma, LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VYLIBRA (NORGESTIMATE AND ETHINYL ESTRADIOL)